Showing 1421-1430 of 2526 results for "".
- UnitedHealthcare Enhances Eye Care Program by Helping Reduce People’s Exposure to Blue Lighthttps://modernod.com/news/unitedhealthcare-enhances-eye-care-program-by-helping-reduce-peoples-exposure-to-blue-light/2480563/UnitedHealthcare is investing in new ways to help children and adults across the country reduce their exposure to blue light and support their overall eye health amid ongoing use of screens during COVID-19 and the greater reliance on remote school and work. Through multiple initiatives,
- Using Cryo-Electron Tomography, UCI Researchers Reveal Molecular Mechanisms Underlying Mutations Within the Eye that Lead to Blindnesshttps://modernod.com/news/using-cryo-electron-tomography-uci-researchers-reveal-molecular-mechanisms-underlying-mutations-within-the-eye-that-lead-to-blindness/2480552/For the first time, University of California, Irvine researchers in collaboration with the Max-Planck Institute of Biochemistry, have revealed at a molecular level key structural determinants of the highly specialized rod outer segment (ROS) membrane architecture of the eye, which is instrum
- I-MED Pharma USA Gains Exclusive Distribution Rights for ESW Vision’s E>Eye and Tearcheck in the United Stateshttps://modernod.com/news/i-med-pharma-usa-gains-exclusive-distribution-rights-for-esw-visions-eeye-and-tearcheck-in-the-united-states/2480505/I-MED Pharma has announced the expansion of their strategic partnership with ESW Vision in France to be their exclusive distributor in the United States. Through I-MED Pharma USA, two dry eye devices will be available directly to all eye care professionals across the country. E>Eye i
- Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycledhttps://modernod.com/news/bausch-lomb-reports-more-than-41-million-units-of-contact-lens-eye-and-lens-care-materials-recycled/2480448/Bausch + Lomb announced its exclusive ONE by ONE and Biotrue Eye Care Recycling programs have recycled a total of 41,358,603 million units, or 248,516 pounds, of used contact lens, eye and lens care materials. The programs are made possible through a collaboration with TerraCycle, a world le
- Unity Biotechnology Announces Improvement in Visual Acuity Sustained Through 24 Weeks in Phase 1 Study of Patients with Advanced Vascular Eye Diseasehttps://modernod.com/news/unity-biotechnology-announces-improvement-in-visual-acuity-sustained-through-24-weeks-in-phase-1-study-of-patients-with-advanced-vascular-eye-disease/2480419/Unity Biotechnology announced 24-week data from its phase 1 single ascending dose (SAD) safety study of UBX1325 in patients wit
- Atsena Therapeutics Unveils XLRS Gene Therapy Program Leveraging Novel Spreading Capsidshttps://modernod.com/news/atsena-therapeutics-unveils-xlrs-gene-therapy-program-leveraging-novel-spreading-capsids/2480355/Atsena Therapeutics unveiled its preclinical gene therapy program for X-linked retinoschisis (XLRS), a monogenic disease caused by mutations in the RS1 gene. XLRS is characterized by schisis, or abnormal splitting of the layers of the retina, which causes impa
- Visus Unveils Additional Ophthalmic Drug Candidates for Corneal Wound Healing, Glaucoma and AMDhttps://modernod.com/news/visus-unveils-additional-ophthalmic-drug-candidates-for-corneal-wound-healing-glaucoma-and-amd/2480276/During its inaugural Capital Markets Day in New York City, Visus Therapeutics unveiled additional ophthalmic drug candidates with applications in development for corneal wound healing, glaucoma and age-related macular degeneration (AMD). Additionally, the company introduced a novel drug
- Pixium Vision Expands Collaboration with Stanford University On Next Generation Prima System Implantshttps://modernod.com/news/pixium-vision-expands-collaboration-with-stanford-university-on-next-generation-prima-system-implants/2479492/Pixium Vision SA announced the expansion of a collaboration with academic partner Stanford University to develop the second generation of implants for its bionic vision Prima System for dry age-related macular degeneration (AMD). “We are very excited to be extending our collaboration with
- United Nations Resolution Designed to Tackle Preventable Sight Losshttps://modernod.com/news/united-nations-resolution-designed-to-tackle-preventable-sight-loss/2479406/The United Nations General Assembly (UNGA) has adopted
- Unity Biotechnology Announces Positive Data From Phase 1 Clinical Trial of UBX1325 in Patients With Advanced Vascular Eye Diseasehttps://modernod.com/news/unity-biotechnology-announces-positive-data-from-phase-1-clinical-trial-of-ubx1325-in-patients-with-advanced-vascular-eye-disease/2479342/Unity Biotechnology announced positive data from its phase 1 safety study of UBX1325 in patients with advanced disease from DME or wet AMD for whom anti-VEGF therapy was no longer considered beneficial. UBX1325, a small molecule inhibitor of Bcl-xL and the first senolytic therapeu